International Immunology Advance Access originally published online on December 13, 2005
International Immunology 2006 18(1):183-198; doi:10.1093/intimm/dxh361
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease
1 Department of Immunology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan
2 Genome Research Department, National Institute of Agrobiological Science, Tsukuba, Ibaraki 305-8602, Japan
3 Present address: Department of Pharmacology, Kinki University School of Medicine, Osaka-Sayama, Osaka 589-8511, Japan
4 Present address: Division of Experimental Immunology, Institute for Genome Research, University of Tokushima, Tokushima 770-8503, Japan
5 Present address: Department of Pediatrics, Kinki University School of Medicine, Osaka-Sayama, Osaka 589-8511, Japan
Correspondence to: M. Miyazawa; E-mail: masaaki{at}med.kindai.ac.jp
CD8+ CTLs and virus-neutralizing antibodies have been associated with spontaneous and vaccine-induced immune control of retroviral infections. We previously showed that a single immunization with an env gene-encoded CD4+ T cell epitope protected mice against fatal Friend retrovirus infection. Here, we analyzed immune cell components required for the peptide-induced anti-retroviral protection. Mice lacking CD8+ T cells were nevertheless protected against Friend virus infection, while mice lacking B cells were not. Virus-producing cells both in the spleen and bone marrow decreased rapidly in their number and became undetectable by 4 weeks after infection in the majority of the peptide-immunized animals even in the absence of CD8+ T cells. In the vaccinated animals the production and class switching of virus-neutralizing and anti-leukemia cell antibodies were facilitated; however, virus-induced erythroid cell expansion was suppressed before neutralizing antibodies became detectable in the serum. Further, the numbers of virus-producing cells in the spleen and bone marrow in the early stage of the infection were smaller in the peptide-immunized than in unimmunized control mice in the absence of B cells. Thus, peptide immunization facilitates both early cellular and late humoral immune responses that lead to the effective control of the retrovirus-induced disease, but CD8+ T cells are not crucial for the elimination of virus-infected cells in the peptide-primed animals.
Keywords: B cell-deficient, ß2-microglobulin-deficient, CD4+ T, epitope, vaccine
Transmitting editor: K. Sugamura
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Bayer, M. Tenbusch, R. Lietz, L. Johrden, S. Schimmer, K. Uberla, U. Dittmer, and O. Wildner Vaccination with an Adenoviral Vector That Encodes and Displays a Retroviral Antigen Induces Improved Neutralizing Antibody and CD4+ T-Cell Responses and Confers Enhanced Protection J. Virol., February 15, 2010; 84(4): 1967 - 1976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Pike, A. Filby, M. J.-Y. Ploquin, U. Eksmond, R. Marques, I. Antunes, K. Hasenkrug, and G. Kassiotis Race between Retroviral Spread and CD4+ T-Cell Response Determines the Outcome of Acute Friend Virus Infection J. Virol., November 1, 2009; 83(21): 11211 - 11222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Takeda, S. Tsuji-Kawahara, M. Sakamoto, M.-A. Langlois, M. S. Neuberger, C. Rada, and M. Miyazawa Mouse APOBEC3 Restricts Friend Leukemia Virus Infection and Pathogenesis In Vivo J. Virol., November 15, 2008; 82(22): 10998 - 11008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Marques, I. Antunes, U. Eksmond, J. Stoye, K. Hasenkrug, and G. Kassiotis B Lymphocyte Activation by Coinfection Prevents Immune Control of Friend Virus Infection J. Immunol., September 1, 2008; 181(5): 3432 - 3440. [Abstract] [Full Text] [PDF]
|
|